Turna Ray

WIN Consortium researchers have shown that a prototype "digital display precision predictor" may identify patents who will live longer on treatments without progression.

A case series in partnership with My Gene Counsel to highlight the challenges genetics professionals and oncologists are grappling with as genetic testing is increasingly used in patient care.

At the annual meeting, researchers demonstrated how the growing real-world database can be useful in answering myriad research questions.

At the AACR Annual Meeting, Sharpless said NCI should focus on improving early screening, access to trials, and development of advanced drugs to realize President Biden's goal of eradicating cancer.

Although the trial didn't hit its prespecified response target to Opdivo and Yervoy, researchers will further study the promising signals they saw in biomarker groups.

Colorectal Cancer Canada, which led the survey, will share the data with decisionmakers, hoping to increase understanding of access barriers and change health policy.  

A case series in partnership with My Gene Counsel to highlight the challenges genetics professionals and oncologists are grappling with as genetic testing is increasingly used in patient care.

Although the logistics still need to be worked out, the partners hope to streamline oncologists' experience ordering tests that can inform patient care.

Cancer centers and drugmakers are collaborating to identify standard procedures for improving access to biomarker testing and personalized treatment.

A case series in partnership with My Gene Counsel to highlight the challenges genetics professionals and oncologists are grappling with as genetic testing is increasingly used in patient care.